Abstract:Human plasminogen kringle 5 (K5) is known to display its potent anti-angiogenesis effect through inducing endothelial cell (EC) apoptosis, and the voltage-dependent anion channel 1 (VDAC1) has been identified as a receptor of K5. However, the exact role and underlying mechanisms of VDAC1 in K5-induced EC apoptosis remain elusive. In the current study, we showed that K5 increased the protein level of VDAC1, which initiated the mitochondrial apoptosis pathway of ECs. Our findings also showed that K5 inhibited the ubiquitin-dependent degradation of VDAC1 by promoting the phosphorylation of VDAC1, possibly at Ser-12 and Thr-107. The phosphorylated VDAC1 was attenuated by the AKT agonist, glycogen synthase kinase (GSK) 3β inhibitor, and siRNA, suggesting that K5 increased VDAC1 phosphorylation via the AKT-GSK3β pathway. Furthermore, K5 promoted cell surface translocation of VDAC1, and binding between K5 and VDAC1 was observed on the plasma membrane. HKI protein blocked the impact of K5 on the AKT-GSK3β pathway by competitively inhibiting the interaction of K5 and cell surface VDAC1. Moreover, K5-induced EC apoptosis was suppressed by VDAC1 antibody. These data show for the first time that K5-induced EC apoptosis is mediated by the positive feedback loop of "VDAC1-AKT-GSK3β-VDAC1," which may provide new perspectives on the mechanisms of K5-induced apoptosis. Human plasminogen kringle 5 (K5) is known to display its potent anti-angiogenesis effect through inducing endothelial cell (EC) apoptosis, and the voltage-dependent anion channel 1 (VDAC1) has been identified as a receptor of K5. However, the exact role and underlying mechanisms of VDAC1 in K5-induced EC apoptosis remain elusive. In the current study, we showed that K5 increased the protein level of VDAC1, which initiated the mitochondrial apoptosis pathway of ECs. Our findings also showed that K5 inhibited the ubiquitin-dependent degradation of VDAC1 by promoting the phosphorylation of VDAC1, possibly at Ser-12 and Thr-107. The phosphorylated VDAC1 was attenuated by the AKT agonist, glycogen synthase kinase (GSK) 3β inhibitor, and siRNA, suggesting that K5 increased VDAC1 phosphorylation via the AKT-GSK3β pathway. Furthermore, K5 promoted cell surface translocation of VDAC1, and binding between K5 and VDAC1 was observed on the plasma membrane. HKI protein blocked the impact of K5 on the AKT-GSK3β pathway by competitively inhibiting the interaction of K5 and cell surface VDAC1. Moreover, K5-induced EC apoptosis was suppressed by VDAC1 antibody. These data show for the first time that K5-induced EC apoptosis is mediated by the positive feedback loop of "VDAC1-AKT-GSK3β-VDAC1," which may provide new perspectives on the mechanisms of K5-induced apoptosis.

Kringle 5 of Human Plasminogen Suppresses Hepatocellular Carcinoma Growth Both in Grafted and Xenografted Mice by Anti-Angiogenic Activity

Inhibition of K5 on Neovascularization and Growth of Mouse Hepatocarcinoma

Plasminogen Kringle 5 Deletion Mutant I Inhibits the Neovascularization and Growth of the Mouse Hepatocarcinoma

High Efficacy and Minimal Peptide Required for the Anti-Angiogenic and Anti-Hepatocarcinoma Activities of Plasminogen K5.

Dual Inhibition Of Plasminogen Kringle 5 On Angiogenesis And Chemotaxis Suppresses Tumor Metastasis By Targeting Hif-1 Alpha Pathway

Inhibition of Human Plasminogen Kringle 5 on Growth and Metastasis of Lewis Lung Carcinoma in Vivo

[Effects of Human Plasminogen Kringle 5 Gene Therapy on Pancreatic Cancer].

Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1|[alpha]| and GRP78

Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1 α and GRP78

BIOMEDICAL APPLICATION OF K5 PLASMINOGEN FRAGMENT

[A Deletion Mutant of Plasminogen Kringle 5 Inhibits Retinal Capillary Endothelial Cell Proliferation].

Studying and Progression of Human Plasminogen Kringle 5

Anti-angiogenic Activity of Plasminogen Kringle 5 Depending on Its Intact Kringle Domain

Combination of Human Plasminogen Kringle 5 with Ionizing Radiation Significantly Enhances the Efficacy of Antitumor Effect.

293. Sustained Expression of Kringle 1 Domain of Human Hepatocyte Growth Factor (HGFK1) Effectively Inhibits Angiogenesis, Growth and Metastasis of Hepatocellular Carcinoma

[Preparation and Functional Study of an Adenovirus Vector Expressing Human Plasminogen Kringle 5 Gene].

Plasminogen Kringle 5 Induces Endothelial Cell Apoptosis by Triggering a Voltage-dependent Anion Channel 1 (VDAC1) Positive Feedback Loop

Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.

Modification Of Cyclic Ngr Tumor Neovasculature-Homing Motif Sequence To Human Plasminogen Kringle 5 Improves Inhibition Of Tumor Growth

Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor

Inhibitory effects of plasminogen K5 combined chemotherapy and radiotherapy on S180 solid tumor in mice